Physician profile
Bryan Johnson
NPI 1598732737
$2,908.36
in general payments reported to CMS, 2019-2025
13 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,161 · 2022: $875 · 2023: $562 · 2024: $72.30 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,150.69 | 2021-2025 | Proclaim, Infinity, Exclaim |
| Abbvie INC. | $241.00 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $134.64 | 2021-2024 | Belbuca |
| Nalu Medical, INC. | $85.40 | 2022 | |
| Medtronic, INC. | $61.70 | 2022-2023 | Synchromedii |
| Ibsa Pharma INC. | $57.38 | 2021-2023 | Tirosint, Licart |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.40 | 2022-2023 | Relistor |
| Biohaven Pharmaceutical Holding Company LTD. | $39.12 | 2022 | |
| Relievant Medsystems, INC. | $33.79 | 2023 | Intracept |
| Lilly USA, LLC | $18.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.57 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.14 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.